Cardiff Oncology Q1 EPS $(0.20) Misses $(0.19) Estimate, Sales $109.00K Beat $96.43K Estimate

Benzinga · 4d ago
Cardiff Oncology (NASDAQ:CRDF) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 9.09 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $109.00 thousand which beat the analyst consensus estimate of $96.43 thousand by 13.04 percent. This is a 46.83 percent decrease over sales of $205.00 thousand the same period last year.